Compare AU

Compare DRUG vs. QLTY

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the BetaShares Global Quality Leaders ETF (QLTY). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

QLTY

Popularity

Low

Low

Pearlers invested

63

94

Median incremental investment

$990.50

$1,243.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,910.37

$4,635.65

Average age group

26 - 35

> 35


Key Summary

DRUG

QLTY

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

QLTY.AX was created on 2018-11-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. QLTY.AX aims to track an index (before fees and expenses) that comprises 150 global companies (ex-Australia) ranked by highest quality score

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

ADOBE INC (2.38 %)

ACCENTURE PLC (2.22 %)

INTUIT INC (2.16 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Other (33.29 %)

Information Technology (28.66 %)

Industrials (9.15 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (67.42 %)

Japan (10.43 %)

Switzerland (4.55 %)

Management fee

0.57 %

0.35 %


Key Summary

DRUG

QLTY

Issuer

BetaShares

BetaShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

iSTOXX MUTB Global ex-Australia Quality Leaders Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.35 %

Price

$8.27

$32.23

Size

$182.401 million

$650.034 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

2.61 %

Market

ASX

ASX

First listed date

08/08/2016

07/11/2018

Purchase fee

$6.50

$6.50


Community Stats

DRUG

QLTY

Popularity

Low

Low

Pearlers invested

63

94

Median incremental investment

$990.50

$1,243.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,910.37

$4,635.65

Average age group

26 - 35

> 35


Pros and Cons

DRUG

QLTY

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

DRUG

QLTY

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home